Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Selank

Selanc, TP-7

Quick Stats
Studies 114
Trials 11
Score 1
2017 pubmed 2 citations

Effect of Selank on Spontaneous Synaptic Activity of Rat Hippocampal CA1 Neurons.

Povarov. I S IS; Kondratenko. R V RV; Derevyagin. V I VI; Myasoedov. N F NF; Skrebitsky. V G VG

Key Findings

  • Selank increased amplitude and discharge rate of spontaneous inhibitory postsynaptic currents in rat CA1 neurons
  • Some neurons showed a transient decrease before the increase
  • No significant dose‑dependence observed between 1‑8 µM

Practical Outcomes

  • The findings are interesting for understanding Selank’s brain activity but don’t translate into actionable dosing or protocols for humans. Biohackers should wait for human‑focused studies before incorporating Selank for anxiety or cognitive benefits.

Summary

In a lab study on rat brain slices, the anxiety‑relief peptide Selank boosted the strength and frequency of natural inhibitory signals in hippocampal neurons, though some cells showed a brief dip before the boost and the effect didn’t change much across the tested concentrations. This is basic neuroscience and doesn’t give clear guidance for human use.

Abstract

Application of anxiolytic drug Selank to hippocampal slices increased the amplitude and discharge rate of spontaneous inhibitory postsynaptic currents in rat hippocampal pyramidal CA1 neurons. In some neurons, Selank-induced up-regulation of spontaneous inhibitory postsynaptic currents was preceded by a transient decrease in this activity. In the examined concentration range (1-8 μM), Selank demonstrated no significant dose-dependence.

Study Information

Provider

pubmed

Year

2017

Date

2017-03-30T00:00:00.000Z

DOI

10.1007/s10517-017-3676-3

Citations

2

References

14